Zimbabwe has declined a major American health deal worth 367 million US dollars (272 million pounds) spanning five years due to Washington's insistence on confidential data.
The decision became public after a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative later explained that the United States was demanding access to biological samples for research and commercial gain while was unwilling to guarantee the resulting advantages from future treatments.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for continued dialogue to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Context
This rejection comes after a comparable situation in Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the safety of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance transparency and accountability.
According to statements, 16 African countries have to date signed these new agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to share its genetic material and health information for a long time, without any equivalent assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Put simply, our nation would provide the raw materials for scientific discovery without any certainty that the resulting innovations would be accessible to our population if a new disease outbreak emerge."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures already established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This framework is intended to ensure that when a country provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome continued discussions with our US partners on how subsequent collaboration might be structured in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts expressed it understood the official position, but recommended that talks need to persist given that much of the nation's HIV programmes depended on international support.
"If technical issues exist, including those involving data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," the group commented.
This impasse underscores the ongoing debate between accepting much-needed foreign assistance and safeguarding a country's data in an ever more interconnected world.